Stephens sees attractive entry point, upgrades Acadia Healthcare to Overweight

As previously reported, Stephens upgraded Acadia Healthcare to Overweight from Equal Weight with a price target of $92, up from $81. While the firm says it has recognized the attractive long-term investment thesis for what it calls “the leading pure-play operator in behavioral,” it has also been waiting for an attractive entry point in the stock, which it now sees having materialized as the firm rolls its price target to 2025 estimates. The stock has “largely traded sideways since late 2022,” despite the company delivering on its growth plans in 2023, the analyst added.